EngineeringMicrobiology2(2022)100023  
Contents lists available at ScienceDirect 
Engineering Microbiology 
journal homepage: www.elsevier.com/locate/engmic 
Research Highlights 
Multifunctional biocatalysis: An unusual imine reductase 
Feifei Chen, Jianhe Xu, Gaowei Zheng ‚àó 
State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology, 
Shanghai 200237, China 
a r t i c l e i n f o 
Keywords: 
Imine reductase 
Biocatalysis 
Chiral amine 
Conjugate reduction 
Reductive amination 
a b s t r a c t 
A multifunctional biocatalyst EneIRED capable of catalyzing amine-activated conjugate alkene reduction and 
subsequent reductive amination was discovered. The enzyme realized the coupling of ùõº, ùõΩ-unsaturated carbonyls 
with amines to eÔ¨Éciently synthesize a broad set of chiral amine diastereomers based on its unusual active site 
structure and catalytic mechanism. 
Structurally diverse chiral amines are ubiquitous structural motifs 
in biologically active compounds such as natural products and drugs 
[ 1 , 2 ]. The eÔ¨Écient synthesis of chiral amines has received signiÔ¨Å- 
cant interest, as demonstrated by the development of various synthetic 
routes involving diastereoisomeric crystallization, asymmetric reduc- 
tive amination of prochiral ketones, reduction of imines or enimines, 
and C-H amination [3] . Amino compounds typically contain more than 
one stereogenic center, and their asymmetric synthesis with adequate 
(dia)stereoselectivity is challenging and usually requires tedious mul- 
tistep syntheses or intricated cascade catalysis systems [ 4 , 5 ]. Multi- 
enzymatic cascades provide new opportunities for preparing amino 
compounds with multiple stereogenic centers, but their application is 
hampered by issues such as incompatibility in the reaction system, gen- 
eration of byproducts, and complicated work-up [ 6 , 7 ]. Now, Turner and 
collaborators have discovered a multifunctional biocatalyst EneIRED 
from a panel of metagenomic imine reductases (IREDs), which can cat- 
alyze both amine-activated conjugate reduction (CR) of alkenes and fol- 
lowing reductive amination (RA), thus achieving the coupling of ùõº, ùõΩ- 
unsaturated carbonyls with amines for the eÔ¨Écient synthesis of diverse 
chiral amine diastereomers ( Fig. 1 ) [8] . 
IREDs are a family of NADPH-dependent enzymes and are involved 
in the reduction of C = N bonds and reductive amination of C = O bonds 
[9] . Furthermore, in a few cases, IREDs have been shown to catalyze 
the direct reduction of C = O bonds to form corresponding alcohol prod- 
ucts [10] . However, the biocatalytic reduction of C = C bonds was still an 
unexplored area for IREDs, whereas the reaction has typically been per- 
formed with ene-reductases (EREDs) [11] . After screening a total of 389 
IREDs, including both reported and recently developed (meta)genomic 
IREDs [12] with a cyclic ene-imine as the model substrate, 44 enzymes 
were found that could catalyze the asymmetric reduction of both the 
C = C and the C = N bonds of the model substrate. Among them, an IRED, 
‚àó Corresponding author. 
E-mail address: gaoweizheng@ecust.edu.cn (G. Zheng) . 
presumably from Pseudomonas species (EneIRED), displayed excellent 
reactivity for the double reduction CR-RA. 
Under optimized conditions, EneIRED exhibited a broad sub- 
strate proÔ¨Åle, enabling CR-RA, mono-CR, or mono-RA of diverse ùõº, ùõΩ- 
unsaturated carbonyls with ammonia or varied amines. Less hindered 
enals and enones as well as amine nucleophiles tend to be converted 
with good chemoselectivity to the corresponding saturated amine prod- 
ucts. For example, coupling of ( E )-2-methyl-2-butenal with cyclopropy- 
lamine aÔ¨Äorded > 99% conversion to the saturated amine. Further- 
more, unsubstituted and substituted cycloalkyl-2-enones with diÔ¨Äer- 
ent ring sizes were well tolerated by the enzyme, aÔ¨Äording good con- 
version and chemo- and stereoselectivity for many of the correspond- 
ing CR‚ÄìRA products. In particular, C 3 -substitutioned cyclohex-2-enone 
substrates were eÔ¨Éciently transformed to CR‚ÄìRA products even when 
coupled with diÔ¨Äerent amine partners ( e.g., NH 3 , methylamine, ally- 
lamine, propargylamine, n -butanamine, pyrrolidine, and ( R )- or ( S )-3- 
Ô¨Çuoropyrrolidine), yielding high conversion and chemo-, enantio- and 
diastereoselectivity in many cases. The enzymatic CR-RA also demon- 
strated great synthetic applicability, with 60‚Äì81% isolated yield for the 
preparative synthesis of the saturated amine products. In one case, 64% 
isolated yield was attained at a scale of 1.0 mmol. 
The unusual function of EneIRED inspired the researchers to con- 
duct mechanistic investigations into the enzymatic catalysis. Isotopic 
labelling experiments using regenerated deuterated nicotinamide cofac- 
tor to transform 3-methyl-2-cyclohexenone with cyclopropylamine as an 
amine partner showed that hydride transfer occurs at the C-1 and C-3 po- 
sitions of the carbonyl substrate. A reaction time-course study and sev- 
eral control experiments suggested that the enone substrate Ô¨Årst under- 
goes CR to the corresponding ketone before transformation into the sat- 
urated amine via RA, and an ene-imine-NAD(P)H-biocatalyst complex 
could be essential for EneIRED-catalyzed CR. The researchers further 
https://doi.org/10.1016/j.engmic.2022.100023 
Received 1 May 2022; Received in revised form 7 May 2022; Accepted 12 May 2022 
Available online 13 May 2022 
2667-3703/¬©2022 The Authors. Published by Elsevier B.V. on behalf of Shandong University. This is an open access article under the CC BY license 
( http://creativecommons.org/licenses/by/4.0/ ) 
F. Chen, J. Xu and G. Zheng Engineering Microbiology 2 (2022) 100023 
Fig. 1. Proposed catalytic cycle of EneIRED-catalyzed CR‚ÄìRA. ùõº, ùõΩ-Unsaturated carbonyls with amine partners were transformed into the corresponding stereoenriched 
saturated amines through EneIRED-catalyzed CR and RA. Adapted from reference [8] . 
resolved the structure of EneIRED to obtain structural insights into the 
catalytic mechanism. Consequently, structural features were observed 
in the active site compared to the other IREDs with released structures 
in the database, and residues Y177 and Y181 proved to play signiÔ¨Åcant 
roles in the CR-RA. Molecular docking of the enzyme with the result- 
ing ene-imine intermediate suggests that the prochiral carbon atom of 
the C = C bond is positioned at a suitable distance to transfer the hy- 
dride from the pyridinium ring of the cofactor. Based on mechanistic and 
structural studies, an EneIRED catalytic cycle of CR-RA was delineated 
by the researchers ( Fig. 1 ). First, the nicotinamide cofactor NAD(P)H 
and the formed ene-imine intermediate from ùõº, ùõΩ-unsaturated carbonyl 
and amine partner are accepted in the active site of EneIRED, generat- 
ing an ene-imine-NAD(P)H-enzyme complex. The hydride is then trans- 
ferred from nicotinamide cofactor to the C-3 of the ene-imine due to its 
beneÔ¨Åcial orientation, whereby CR occurs and generates the stereoen- 
riched 1-enamine-NAD(P) + -EneIRED complex. The prochiral 1-enamine 
and NAD(P) + are then released from the active site, and the former un- 
dergoes hydrolysis to the stereoenriched carbonyl. Subsequently, the in- 
termediate imine is formed from the stereoenriched carbonyl and the 
amine partner and complexed with the enzyme and nicotinamide cofac- 
tor NAD(P)H, which is transformed into the Ô¨Ånal stereoenriched amine 
product via IRED-catalyzed RA. 
The identiÔ¨Åcation of new enzymes and new activities of previously 
discovered enzymes plays a signiÔ¨Åcant role in extending the synthetic 
scope of biocatalysis and pushing forward its application in the manu- 
facture of high-value chiral compounds [ 13 , 14 ]. Although the catalysis 
of IREDs, especially in the synthesis of chiral amines, has been widely 
investigated in the last decade [ 9 , 15‚Äì17 ], the identiÔ¨Åcation of the mul- 
tifunctional biocatalyst EneIRED provides new perspectives in the bio- 
catalytic area due to this newly disclosed function for C = C reduction 
[8] . The CR-RA catalysis enabled by EneIRED in a one-pot, one-catalyst 
fashion provides a concise, green, and eÔ¨Écient route to stereoenriched 
amine products with multiple stereogenic centers. This is a signiÔ¨Åcant 
discovery that improves upon previously developed methods, consid- 
ering the existing issues associated with cost, operational complexity, 
environmental impact, and product quality [4‚Äì7] . 
The catalytic mechanism and chemoselectivity to imine reduction, 
reductive amination, and ketoreduction have been widely studied for 
IREDs with structural insights [ 15 , 17 , 18 ]. Nevertheless, the identiÔ¨Åca- 
tion of the new CR-RA function of IREDs with structural investigations 
2 
F. Chen, J. Xu and G. Zheng Engineering Microbiology 2 (2022) 100023 
sheds new light on understanding of the structure-activity relationships 
of the family of IREDs, which provides guidance for the laboratory evo- 
lution of the enzymes to enable the synthesis of structurally diÔ¨Äerent 
chiral amines of interest. The study will likely inspire further exploration 
or creation of new enzyme activities for other NAD(P)H-dependent en- 
zyme families ( e.g., amine dehydrogenases [ 19 , 20 ]) based on structural 
study and by virtue of advances in protein engineering [21] . 
Declaration of Competing Interest 
The authors declare that they have no known competing Ô¨Ånancial 
interests or personal relationships that could have appeared to inÔ¨Çuence 
the work reported in this paper. 
Acknowledgments 
This work was supported by the National Natural Science Founda- 
tion of China ( 22008068 , 21878085 ) and the China Postdoctoral Science 
Foundation ( 2020M671027 ). 
References 
[1] M. H√∂hne, U.T. Bornscheuer, Biocatalytic routes to optically active amines, Chem- 
CatChem 1 (2009) 42‚Äì51, doi: 10.1002/cctc.200900110 . 
[2] T.C. Nugent, M. El-Shazly, Chiral amine synthesis-recent developments and trends 
for enamide reduction, reductive amination, and imine reduction, Adv. Synth. Catal. 
352 (2010) 753‚Äì819, doi: 10.1002/adsc.200900719 . 
[3] D. Ghislieri, N.J. Turner, Biocatalytic approaches to the synthesis of enan- 
tiomerically pure chiral amines, Top. Catal. 57 (2014) 284‚Äì300, doi: 10.1007/ 
s11244-013-0184-1 . 
[4] T. Li, J. Liang, A. Ambrogelly, T. Brennan, G. Gloor, G. Huisman, J. Lalonde, 
A. Lekhal, B. Mijts, S. Muley, L. Newman, M. Tobin, G. Wong, A. Zaks, X.Y. Zhang, 
EÔ¨Écient, chemoenzymatic process for manufacture of the boceprevir bicyclic 
[3.1.0]proline intermediate based on amine oxidase-catalyzed desymmetrization, J. 
Am. Chem. Soc. 134 (2012) 6467‚Äì6472, doi: 10.1021/ja3010495 . 
[5] J. Zhou, B. List, Organocatalytic asymmetric reaction cascade to substituted cyclo- 
hexylamines, J. Am. Chem. Soc. 129 (2007) 7498‚Äì7499, doi: 10.1021/ja072134j . 
[6] D. Monti, M.C. Forchin, M. Crotti, F. Parmeggiani, F.G. Gatti, E. Brenna, S. Riva, 
Cascade coupling of ene-reductases and ùúî -transaminases for the stereoselective syn- 
thesis of diastereomerically enriched amines, ChemCatChem 7 (2015) 3106‚Äì3109, 
doi: 10.1002/cctc.201500424 . 
[7] T.W. Thorpe, S.P. France, S. Hussain, J.R. Marshall, W. Zawodny, J. Mangas- 
Sanchez, S.L. Montgomery, R.M. Howard, D.S.B. Daniels, R. Kumar, F. Parmeggiani, 
N.J. Turner, One-pot biocatalytic cascade reduction of cyclic enimines for the prepa- 
ration of diastereomerically enriched N -heterocycles, J. Am. Chem. Soc. 141 (2019) 
19208‚Äì19213, doi: 10.1021/jacs.9b10053 . 
[8] T.W. Thorpe, J.R. Marshall, V. Harawa, R.E. Ruscoe, A. Cuetos, J.D. Finni- 
gan, A. Angelastro, R.S. Heath, F. Parmeggiani, S.J. Charnock, R.M. Howard, 
R. Kumar, D.S.B. Daniels, G. Grogan, N.J. Turner, Multifunctional biocatalyst 
for conjugate reduction and reductive amination, Nature 604 (2022) 86‚Äì91, 
doi: 10.1038/s41586-022-04458-x . 
[9] G. Grogan, N.J. Turner, InspIRED by nature: NADPH-dependent imine reductases 
(IREDs) as catalysts for the preparation of chiral amines, Chem. Eur. J. 22 (2016) 
1900‚Äì1907, doi: 10.1002/chem.201503954 . 
[10] M. Lenz, J. Meisner, L. Quertinmont, S. Lutz, J. Kastner, B.M. Nestl, Asymmet- 
ric ketone reduction by imine reductases, ChemBioChem 18 (2017) 253‚Äì256, 
doi: 10.1002/cbic.201600647 . 
[11] H.S. Toogood, N.S. Scrutton, Discovery, characterization, engineering, and applica- 
tions of ene-reductases for industrial biocatalysis, ACS Catal. 8 (2018) 3532‚Äì3549, 
doi: 10.1021/acscatal.8b00624 . 
[12] J.R. Marshall, P.Y. Yao, S.L. Montgomery, J.D. Finnigan, T.W. Thorpe, R.B. Palmer, 
J. Mangas-Sanchez, R.A.M. Duncan, R.S. Heath, K.M. Graham, D.J. Cook, 
S.J. Charnock, N.J. Turner, Screening and characterization of a diverse panel of 
metagenomic imine reductases for biocatalytic reductive amination, Nat. Chem. 13 
(2021) 140‚Äì148, doi: 10.1038/s41557-020-00606-w . 
[13] G.W. Huisman, S.J. Collier, On the development of new biocatalytic processes for 
practical pharmaceutical synthesis, Curr. Opin. Chem. Biol. 17 (2013) 284‚Äì292, 
doi: 10.1016/j.cbpa.2013.01.017 . 
[14] H. Kohls, F. SteÔ¨Äen-Munsberg, M. H√∂hne, Recent achievements in developing the 
biocatalytic toolbox for chiral amine synthesis, Curr. Opin. Chem. Biol. 19 (2014) 
180‚Äì192, doi: 10.1016/j.cbpa.2014.02.021 . 
[15] G.A. Aleku, S.P. France, H. Man, J. Mangas-Sanchez, S.L. Montgomery, M. Sharma, 
F. Leipold, S. Hussain, G. Grogan, N.J. Turner, A reductive aminase from Aspergillus 
oryzae , Nat. Chem. 9 (2017) 961‚Äì969, doi: 10.1038/nchem.2782 . 
[16] H. Li, Z.J. Luan, G.W. Zheng, J.H. Xu, EÔ¨Écient synthesis of chiral indolines using an 
imine reductase from Paenibacillus lactis , Adv. Synth. Catal. 357 (2015) 1692‚Äì1696, 
doi: 10.1002/adsc.201500160 . 
[17] J. Mangas-Sanchez, S.P. France, S.L. Montgomery, G.A. Aleku, H. Man, M. Sharma, 
J.I. Ramsden, G. Grogan, N.J. Turner, Imine reductases (IREDs), Curr. Opin. Chem. 
Biol. 37 (2017) 19‚Äì25, doi: 10.1016/j.cbpa.2016.11.022 . 
[18] S.L. Montgomery, A. Pushpanath, R.S. Heath, J.R. Marshall, U. Klemstein, J.L. Gal- 
man, D. Woodlock, S. Bisagni, C.J. Taylor, J. Mangas-Sanchez, J.I. Ramsden, 
B. Dominguez, N.J. Turner, Characterization of imine reductases in reductive am- 
ination for the exploration of structure-activity relationships, Sci. Adv. 6 (2020) 
eaay9320 doi: ARTN eaay932010.1126/sciadv.aay9320 . 
[19] M.J. Abrahamson, E. V√°zquez-Figueroa, N.B. Woodall, J.C. Moore, A.S. Bommarius, 
Development of an amine dehydrogenase for synthesis of chiral amines, Angew. 
Chem. Int. Ed. 51 (2012) 3969‚Äì3972, doi: 10.1002/anie.201107813 . 
[20] O. Mayol, K. Bastard, L. Beloti, A. Frese, J.P. Turkenburg, J.L. Petit, A. Mariage, 
A. Debard, V. Pellouin, A. Perret, V. de Berardinis, A. Zaparucha, G. Gro- 
gan, C. Vergne-Vaxelaire, A family of native amine dehydrogenases for the 
asymmetric reductive amination of ketones, Nat. Catal. 2 (2019) 324‚Äì333, 
doi: 10.1038/s41929-019-0249-z . 
[21] U.T. Bornscheuer, G.W. Huisman, R.J. Kazlauskas, S. Lutz, J.C. Moore, K. Robins, 
Engineering the third wave of biocatalysis, Nature 485 (2012) 185‚Äì194, 
doi: 10.1038/nature11117 . 
3